BDBM752380 (1R,3S,5R)-2-(2-(3-acetyl- 7-methyl-5-(2-methyl- [1,2,4]triazolo[1,5-a]pyr- idin-6-yl)-1H-indol-1-yl)- acetyl)-N-(4-fluoro-3- methyl-6-(trifluorometh- yl)pyridin-2-yl)-5-methyl- 2-azabicyclo[3.1.0]hexane- 3-carboxamide::US20250197403, Compound 58

SMILES CC(=O)c1cn(CC(=O)N2[C@H](C(=O)Nc3nc(C(F)(F)F)cc(F)c3C)C[C@@]3(C)C[C@@H]23)c2c(C)cc(-c3ccc4nc(C)nn4c3)cc12

InChI Key

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 752380   

TargetComplement factor D(Human)
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM752380((1R,3S,5R)-2-(2-(3-acetyl- 7-methyl-5-(2-methyl- [...)
Affinity DataIC50: 1.00E+3nMAssay Description:Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/14/2025
Entry Details
US Patent